[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Endorphins-South America Market Status and Trend Report 2015-2026

May 2020 | 160 pages | ID: EC2FFE0F3C53EN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Endorphins-South America Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Endorphins industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole South America and Regional Market Size of Endorphins 2015-2019, and development forecast 2020-2026
Main market players of Endorphins in South America, with company and product introduction, position in the Endorphins market
Market status and development trend of Endorphins by types and applications
Cost and profit status of Endorphins, and marketing status
Market growth drivers and challenges

The report segments the South America Endorphins market as:

South America Endorphins Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
Brazil
Argentina
Venezuela
Colombia
Others

South America Endorphins Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins

South America Endorphins Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies

South America Endorphins Market: Players Segment Analysis (Company and Product introduction, Endorphins Sales Volume, Revenue, Price and Gross Margin):
Assertio Therapeutics Inc.
Egalet Corp.
Cipher Pharmaceuticals Inc.
Johnson & Johnson
Endo International Plc
Pfizer
Lannett Co. Inc.

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ENDORPHINS

1.1 Definition of Endorphins in This Report
1.2 Commercial Types of Endorphins
  1.2.1 Alpha-Endorphins
  1.2.2 Beta-Endorphins
  1.2.3 Gamma-Endorphins
  1.2.4 Sigma-Endorphins
1.3 Downstream Application of Endorphins
  1.3.1 Institutional Pharmacies
  1.3.2 Retail Pharmacies
  1.3.3 Online Pharmacies
1.4 Development History of Endorphins
1.5 Market Status and Trend of Endorphins 2015-2026
  1.5.1 South America Endorphins Market Status and Trend 2015-2026
  1.5.2 Regional Endorphins Market Status and Trend 2015-2026

CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Endorphins in South America 2015-2019
2.2 Consumption Market of Endorphins in South America by Regions
  2.2.1 Consumption Volume of Endorphins in South America by Regions
  2.2.2 Revenue of Endorphins in South America by Regions
2.3 Market Analysis of Endorphins in South America by Regions
  2.3.1 Market Analysis of Endorphins in Brazil 2015-2019
  2.3.2 Market Analysis of Endorphins in Argentina 2015-2019
  2.3.3 Market Analysis of Endorphins in Venezuela 2015-2019
  2.3.4 Market Analysis of Endorphins in Colombia 2015-2019
  2.3.5 Market Analysis of Endorphins in Others 2015-2019
2.4 Market Development Forecast of Endorphins in South America 2020-2026
  2.4.1 Market Development Forecast of Endorphins in South America 2020-2026
  2.4.2 Market Development Forecast of Endorphins by Regions 2020-2026

CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole South America Market Status by Types
  3.1.1 Consumption Volume of Endorphins in South America by Types
  3.1.2 Revenue of Endorphins in South America by Types
3.2 South America Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Brazil
  3.2.2 Market Status by Types in Argentina
  3.2.3 Market Status by Types in Venezuela
  3.2.4 Market Status by Types in Colombia
  3.2.5 Market Status by Types in Others
3.3 Market Forecast of Endorphins in South America by Types

CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Endorphins in South America by Downstream Industry
4.2 Demand Volume of Endorphins by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Endorphins by Downstream Industry in Brazil
  4.2.2 Demand Volume of Endorphins by Downstream Industry in Argentina
  4.2.3 Demand Volume of Endorphins by Downstream Industry in Venezuela
  4.2.4 Demand Volume of Endorphins by Downstream Industry in Colombia
  4.2.5 Demand Volume of Endorphins by Downstream Industry in Others
4.3 Market Forecast of Endorphins in South America by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ENDORPHINS

5.1 South America Economy Situation and Trend Overview
5.2 Endorphins Downstream Industry Situation and Trend Overview

CHAPTER 6 ENDORPHINS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA

6.1 Sales Volume of Endorphins in South America by Major Players
6.2 Revenue of Endorphins in South America by Major Players
6.3 Basic Information of Endorphins by Major Players
  6.3.1 Headquarters Location and Established Time of Endorphins Major Players
  6.3.2 Employees and Revenue Level of Endorphins Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 ENDORPHINS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Assertio Therapeutics Inc.
  7.1.1 Company profile
  7.1.2 Representative Endorphins Product
  7.1.3 Endorphins Sales, Revenue, Price and Gross Margin of Assertio Therapeutics Inc.
7.2 Egalet Corp.
  7.2.1 Company profile
  7.2.2 Representative Endorphins Product
  7.2.3 Endorphins Sales, Revenue, Price and Gross Margin of Egalet Corp.
7.3 Cipher Pharmaceuticals Inc.
  7.3.1 Company profile
  7.3.2 Representative Endorphins Product
  7.3.3 Endorphins Sales, Revenue, Price and Gross Margin of Cipher Pharmaceuticals Inc.
7.4 Johnson & Johnson
  7.4.1 Company profile
  7.4.2 Representative Endorphins Product
  7.4.3 Endorphins Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.5 Endo International Plc
  7.5.1 Company profile
  7.5.2 Representative Endorphins Product
  7.5.3 Endorphins Sales, Revenue, Price and Gross Margin of Endo International Plc
7.6 Pfizer
  7.6.1 Company profile
  7.6.2 Representative Endorphins Product
  7.6.3 Endorphins Sales, Revenue, Price and Gross Margin of Pfizer
7.7 Lannett Co. Inc.
  7.7.1 Company profile
  7.7.2 Representative Endorphins Product
  7.7.3 Endorphins Sales, Revenue, Price and Gross Margin of Lannett Co. Inc.

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ENDORPHINS

8.1 Industry Chain of Endorphins
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ENDORPHINS

9.1 Cost Structure Analysis of Endorphins
9.2 Raw Materials Cost Analysis of Endorphins
9.3 Labor Cost Analysis of Endorphins
9.4 Manufacturing Expenses Analysis of Endorphins

CHAPTER 10 MARKETING STATUS ANALYSIS OF ENDORPHINS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications